Trial intelligence / Profile preview

PSMA ADC in recurrent glioblastoma multiforme

NCT01856933Phase 2Completed

Sponsor
Heinrich Elinzano
Start
May 2013
Primary completion
Nov 2014
Countries
1
01

Overview

A Phase 2 trial of psma adc in glioblastoma multiforme (GBM), Gliosarcoma (GS), sponsored by Heinrich Elinzano. Started May 2013; status: completed.

02

Drugs

psma adc
03

Conditions

glioblastoma multiforme (GBM)Gliosarcoma (GS)

Beyond the preview

Go deeper on NCT01856933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01856933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call